Vraylar 3 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FXLX3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,298
Award facts
- Contract value 100% obligated
- $17,298.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,298.40 to AmerisourceBergen Drug Corp for the supply of Vraylar 3 mg capsules (30-count units). The contract, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price, competitively awarded transaction with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for federal agencies, particularly the Defense Health Agency and military healthcare systems. Vraylar is a prescription antipsychotic medication used to treat psychiatric disorders, reflecting the company's portfolio of neurological and specialty pharmaceutical treatments. The delivery order exemplifies the Defense Logistics Agency's reliance on AmerisourceBergen's extensive pharmaceutical distribution capabilities to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support U.S. military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FXLX3?
SPE2DB25FXLX3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FXLX3 worth?
The government has obligated $17,298 on SPE2DB25FXLX3.
Is contract SPE2DB25FXLX3 an order under another contract?
Yes. SPE2DB25FXLX3 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXLX3 competed?
The extent of competition for SPE2DB25FXLX3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award